Zacks Investment Research | Jun 13, 2018 09:29PM ET
The rate hike announced in the recently concluded FOMC meeting comes as expected. With the latest raise of one-quarter percentage points at the last held FOMC meeting, the interest rate now stands at 2%. This decision was unanimously favored by all eight members of the regulatory body.
In fact, the odds for four hikes this year has increased. Media reports stated that odds for December hike followed by the one likely in September, increased to 58%, up from 50% according to traders. Federal funds rate is now projected at 2.4%, up from March projection of 2.1%.
For 2019, interest rate is estimated to be 3.1%, up from 2.9% projected at its May FOMC meeting while the same is expected to reach 3.4% at 2020 end.
Major indexes, namely S&P 500, Nasdaq and Dow Jones Industrial Average have lost in yesterday’s trading session.
Strengthening of the U.S. economy propelled the Federal Reserve’s rate raise from its near zero level. The recent increase marks the seventh hike since the financial crisis.
The Fed also provided an optimistic unemployment outlook. Per Bureau of Labor Statistics, unemployment rate in May was 3.8%, lowest in 18 years. Fed officials continue to expect the employment rate at 3.6% for 2018, 3.5% for both 2019 and 2020, down from 3.9% for 2018 and 2019, 4% for 2020 and 4.6% over the longer-term, predicted in its March 2018 FOMC meeting. However, 4.5% unemployment rate over the long run still remains so. A spurt in employment shows an average of 0.2 million jobs growth over the last three months.
Encouraging economic data instills hopes. The Fed now estimates GDP to gain at 2.8% in 2018, up from the March forecast of 2.7%. Expectations thereafter remain in line with the March projections of 2.4% in 2019, 2% in 2020 and 1.8% over the long term.
However, inflation might remain slightly above the targeted 2% through 2020, though the same will stay at 2% thereafter. Inflation is estimated at 2.1% till 2020.
Although an improving rate environment comes as a piece of good news for some, while for others, it descends as bad news. Capital intensive industries worry as cost of capital rises. Meanwhile, banks and insurers remain major beneficiaries of a rising rate environment because of their sensitivity to interest rates.
With the progressing rate environment, investment income — an important component of insurers’ top line — is also exhibiting an upward trend. This apart, tax rate overhaul, advancing economy, encouraging employment data and stringent underwriting standards infuse confidence in the stock among investors.
Insurance Stocks in Focus
Amid an improving macro backdrop, investors always look eagerly to add stocks with strong fundamentals, which are likely to generate better yields.
It’s an intimidating task to zero in on underpriced stocks with a high-growth offer. The industry ’s decline of 5.9% year to date.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Zacks Investment Research
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.